Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 2/20 | 0.39 |
| ▸ | PLA2G10 | O15496 | 3/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.38 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.38 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.38 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.38 |
| ▸ | PLA2G12B | Q9BX93 | 1/20 | 0.38 |
| ▸ | PLA2G12A | Q9BZM1 | 1/20 | 0.38 |
| ▸ | PLA2G2F | Q9BZM2 | 1/20 | 0.38 |
| ▸ | PLA2G3 | Q9NZ20 | 1/20 | 0.38 |
| ▸ | PLA2G2E | Q9NZK7 | 1/20 | 0.38 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.36 |
| ▸ | PPARD | Q03181 | 2/20 | 0.35 |
| ▸ | PPARA | Q07869 | 2/20 | 0.35 |
| ▸ | LDHA | P00338 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5320539 | 0.82 | SLC7A5 (0.53) | HSD17B10PTGS1PTGS2HTR2AALOX15 | |
| SCHEMBL6911871 | 0.81 | GABRA1 (0.41) | HSD17B10PTGS1PTGS2AKR1C3LMNA | |
| SCHEMBL585323 | 0.76 | KDM4E (0.46) | HSD17B10PTGS1AKR1C3LMNAAKR1C2 | |
| SCHEMBL586034 | 0.74 | PTGS2 (0.46) | PTGS1PTGS2AKR1C3AKR1C2SLC22A6 | |
| SCHEMBL11237591 | 0.73 | TBXAS1 (0.59) | TBXAS1FFAR1LDHAPTGS1PTGS2 | |
| SCHEMBL19220318 | 0.72 | CYP3A4 (0.50) | TSHR | |
| SCHEMBL5319999 | 0.71 | SLC7A5 (0.53) | HSD17B10PTGS1PTGS2HTR2AALOX15 | |
| SCHEMBL13857281 | 0.71 | ACACB (0.50) | TBXAS1PLA2G10PLA2G2APLA2G1BPLA2G5 | |
| SCHEMBL8257100 | 0.70 | TBXAS1 (0.53) | TBXAS1PLA2G10PLA2G2APLA2G1BPLA2G5 | |
| Hydrochloric Acid SCHEMBL22494232 | 0.70 | MLNR (0.42) | TBXAS1PPARDHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 424 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3826986-B1 | NOVEL ODORANTS HAVING ROSE ODOUR | SYMRISE AG (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-12545851-B2 | Fragrances with note of lily of the valley | SYMRISE AG (DE) | 2026-02-10 | — | — | US | disclosed |
| EP-4680184-A1 | HIGH PERFORMANCE FRAGRANCE COMPOSITIONS FOR RINSE-OFF CONDITIONER | International Flavors & Fragrances Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| EP-4665291-A1 | TRANSPARENT ALCOHOL-FREE BASE FOR FRAGRANCE COMPOSITIONS | International Flavors & Fragrances Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| EP-3853332-B1 | COMPOSITION | UNILEVER GLOBAL IP LTD (GB) | 2025-12-10 | — | — | EP | disclosed |
| EP-4045490-B1 | NEW AROMATIC MONOTHIOKETALS AS FRAGRANCES | SYMRISE AG (DE) | 2025-12-03 | — | — | EP | disclosed |
| EP-4624559-A2 | ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | Symrise AG (DE) | 2025-10-01 | — | — | EP | disclosed |
| US-12427115-B2 | Hybrid fragrance encapsulate formulation and method for using the same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-09-30 | — | — | US | disclosed |
| US-12421475-B2 | High performing, high impact bloom accord with a top, medium, and base note mixture | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-12409113-B2 | Polyurea or polyurethane capsules | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-09-09 | — | — | US | disclosed |
| EP-1244748-A1 | WAX FORMULATIONS CONTAINING ODORIFEROUS SUBSTANCES | Symrise GmbH & Co. KG (DE) | 2002-10-02 | — | — | EP | disclosed |
| EP-1220850-A2 | 1,4-DIOXACYCLOALKANE-2-ONE AND 1,4-DIOXACYCLOALKENE-2-ONE | HAARMANN & REIMER GMBH (DE) | 2002-07-10 | — | — | EP | disclosed |
| EP-1215189-A1 | Process for the preparation of isolongifolanol | HAARMANN & REIMER GMBH (DE) | 2002-06-19 | — | — | EP | disclosed |
| WO-2002024857-A1 | MULTI-PHASE SOAP | HAARMANN & REIMER GMBH (DE) | 2002-03-28 | — | — | WO | disclosed |
| WO-2002019983-A2 | CLEANSING/CONDITIONING AGENTS CONTAINING MATRIX PARTICLES WITH A PERFUME COMPONENT AND A WASHING-ACTIVE COMPONENT | HAARMANN & REIMER GMBH (DE) | 2002-03-14 | — | — | WO | disclosed |
| WO-2002012157-A1 | NOVEL MACROCYCLIC KETONES | HAARMANN & REIMER GMBH (DE) | 2002-02-14 | — | — | WO | disclosed |
| EP-1111029-A2 | Perfume compositions containing 4,8-dimethyl-3,7-nonadien-2-one | HAARMANN & REIMER GMBH (DE) | 2001-06-27 | — | — | EP | disclosed |
| WO-2001038440-A1 | WAX FORMULATIONS CONTAINING ODORIFEROUS SUBSTANCES | HAARMANN & REIMER GMBH (DE) | 2001-05-31 | — | — | WO | disclosed |
| WO-2001023373-A2 | 1,4-DIOXACYCLOALKANE-2-ONE AND 1,4-DIOXACYCLOALKENE-2-ONE | HAARMANN & REIMER GMBH (DE) | 2001-04-05 | — | — | WO | disclosed |
| EP-1067126-A2 | Tetracyclic acetals | HAARMANN & REIMER GMBH (DE) | 2001-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12409113-B2 | Polyurea or polyurethane capsules | PUF60, PARG, UMPS | TBXAS1 460/4885PLA2G10 601/4885PLA2G2A 548/4885 |
| US-12545851-B2 | Fragrances with note of lily of the valley | TRPA1, CDY1; CDY1B, TMEM109 | TBXAS1 4448/4885PLA2G10 3975/4885PLA2G2A 4814/4885 |
| US-12427115-B2 | Hybrid fragrance encapsulate formulation and method for using the same | CUTA, FAU, FHIT | TBXAS1 2406/4885PLA2G10 2624/4885PLA2G2A 3263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.